Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0351 Transporter Info | ||||
Gene Name | SLC3A1 | ||||
Transporter Name | Neutral and basic amino acid transport protein rBAT | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Hepatocellular carcinoma |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC3A1 in hepatocellular carcinoma | [ 1 ] | |||
Location |
5'UTR (cg14411266) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 3.33E+00 | Statistic Test | p-value: 1.12E-09; Z-score: 5.58E+00 | ||
Methylation in Case |
1.59E-01 (Median) | Methylation in Control | 4.76E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC3A1 in hepatocellular carcinoma | [ 1 ] | |||
Location |
1stExon (cg03217954) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.00E+00 | Statistic Test | p-value: 2.60E-02; Z-score: 6.56E-02 | ||
Methylation in Case |
8.32E-01 (Median) | Methylation in Control | 8.30E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC3A1 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg00990690) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.90E+00 | Statistic Test | p-value: 8.61E-22; Z-score: -4.37E+00 | ||
Methylation in Case |
3.46E-01 (Median) | Methylation in Control | 6.58E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC3A1 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg11634297) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.56E+00 | Statistic Test | p-value: 2.18E-18; Z-score: -3.95E+00 | ||
Methylation in Case |
4.37E-01 (Median) | Methylation in Control | 6.82E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC3A1 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg02770054) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.25E+00 | Statistic Test | p-value: 9.98E-15; Z-score: 4.25E+00 | ||
Methylation in Case |
4.87E-01 (Median) | Methylation in Control | 2.17E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC3A1 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg12033248) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.36E+00 | Statistic Test | p-value: 2.77E-14; Z-score: -5.66E+00 | ||
Methylation in Case |
5.78E-01 (Median) | Methylation in Control | 7.84E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC3A1 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg10801607) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.42E+00 | Statistic Test | p-value: 5.28E-08; Z-score: -1.12E+00 | ||
Methylation in Case |
1.12E-01 (Median) | Methylation in Control | 1.59E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC3A1 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg09959718) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 8.75E-03; Z-score: -2.51E-01 | ||
Methylation in Case |
7.83E-01 (Median) | Methylation in Control | 7.89E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC3A1 in prostate cancer | [ 2 ] | |||
Location |
5'UTR (cg09546172) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.68E+00 | Statistic Test | p-value: 1.71E-02; Z-score: -1.84E+00 | ||
Methylation in Case |
1.28E-01 (Median) | Methylation in Control | 2.15E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC3A1 in prostate cancer | [ 2 ] | |||
Location |
Body (cg15746253) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.27E+00 | Statistic Test | p-value: 1.09E-02; Z-score: -7.59E+00 | ||
Methylation in Case |
6.69E-01 (Median) | Methylation in Control | 8.53E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC3A1 in prostate cancer | [ 2 ] | |||
Location |
Body (cg08518839) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 4.57E-02; Z-score: 1.97E+00 | ||
Methylation in Case |
9.72E-01 (Median) | Methylation in Control | 9.60E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC3A1 in bladder cancer | [ 3 ] | |||
Location |
TSS1500 (cg03902905) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 1.44E-04; Z-score: -2.75E+00 | ||
Methylation in Case |
6.97E-01 (Median) | Methylation in Control | 7.49E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC3A1 in bladder cancer | [ 3 ] | |||
Location |
TSS1500 (cg09067747) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 5.42E-03; Z-score: -2.12E+00 | ||
Methylation in Case |
5.44E-01 (Median) | Methylation in Control | 5.96E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC3A1 in bladder cancer | [ 3 ] | |||
Location |
1stExon (cg02192965) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.28E+00 | Statistic Test | p-value: 8.73E-05; Z-score: -6.52E+00 | ||
Methylation in Case |
6.43E-01 (Median) | Methylation in Control | 8.23E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC3A1 in bladder cancer | [ 3 ] | |||
Location |
Body (cg21843262) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.48E+00 | Statistic Test | p-value: 1.45E-14; Z-score: -4.96E+01 | ||
Methylation in Case |
3.92E-01 (Median) | Methylation in Control | 9.74E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC3A1 in bladder cancer | [ 3 ] | |||
Location |
Body (cg09860050) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.16E+00 | Statistic Test | p-value: 2.65E-14; Z-score: -1.98E+01 | ||
Methylation in Case |
3.30E-01 (Median) | Methylation in Control | 7.15E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC3A1 in bladder cancer | [ 3 ] | |||
Location |
Body (cg24724513) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -3.00E+00 | Statistic Test | p-value: 7.93E-14; Z-score: -1.40E+01 | ||
Methylation in Case |
2.27E-01 (Median) | Methylation in Control | 6.81E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC3A1 in bladder cancer | [ 3 ] | |||
Location |
Body (cg10801607) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.46E+00 | Statistic Test | p-value: 2.73E-05; Z-score: -3.94E+00 | ||
Methylation in Case |
9.32E-02 (Median) | Methylation in Control | 1.36E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC3A1 in bladder cancer | [ 3 ] | |||
Location |
Body (cg09959718) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.17E+00 | Statistic Test | p-value: 6.10E-05; Z-score: -6.23E+00 | ||
Methylation in Case |
6.69E-01 (Median) | Methylation in Control | 7.83E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC3A1 in breast cancer | [ 4 ] | |||
Location |
TSS1500 (cg09067747) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 1.79E-02; Z-score: -5.05E-01 | ||
Methylation in Case |
5.40E-01 (Median) | Methylation in Control | 5.72E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC3A1 in breast cancer | [ 4 ] | |||
Location |
1stExon (cg02192965) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 7.74E-05; Z-score: -1.23E+00 | ||
Methylation in Case |
6.98E-01 (Median) | Methylation in Control | 7.60E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC3A1 in breast cancer | [ 4 ] | |||
Location |
1stExon (cg03217954) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 1.91E-03; Z-score: -7.16E-01 | ||
Methylation in Case |
8.46E-01 (Median) | Methylation in Control | 8.62E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC3A1 in breast cancer | [ 4 ] | |||
Location |
Body (cg09860050) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.18E+00 | Statistic Test | p-value: 8.91E-14; Z-score: -3.92E+00 | ||
Methylation in Case |
6.12E-01 (Median) | Methylation in Control | 7.20E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC3A1 in breast cancer | [ 4 ] | |||
Location |
Body (cg21843262) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 7.39E-12; Z-score: -5.30E+00 | ||
Methylation in Case |
8.49E-01 (Median) | Methylation in Control | 9.65E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC3A1 in breast cancer | [ 4 ] | |||
Location |
Body (cg24724513) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.33E+00 | Statistic Test | p-value: 2.78E-08; Z-score: -1.44E+00 | ||
Methylation in Case |
5.14E-01 (Median) | Methylation in Control | 6.82E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC3A1 in breast cancer | [ 4 ] | |||
Location |
Body (cg10801607) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.40E+00 | Statistic Test | p-value: 2.04E-04; Z-score: 1.56E+00 | ||
Methylation in Case |
1.69E-01 (Median) | Methylation in Control | 1.21E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC3A1 in breast cancer | [ 4 ] | |||
Location |
Body (cg09959718) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.75E-03; Z-score: -2.39E-01 | ||
Methylation in Case |
7.88E-01 (Median) | Methylation in Control | 7.95E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC3A1 in colorectal cancer | [ 5 ] | |||
Location |
TSS1500 (cg09067747) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 1.92E-09; Z-score: -2.00E+00 | ||
Methylation in Case |
5.89E-01 (Median) | Methylation in Control | 6.58E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC3A1 in colorectal cancer | [ 5 ] | |||
Location |
TSS1500 (cg03902905) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 4.05E-07; Z-score: -1.50E+00 | ||
Methylation in Case |
6.93E-01 (Median) | Methylation in Control | 7.54E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC3A1 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg09959718) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.12E-02; Z-score: -2.73E-01 | ||
Methylation in Case |
9.30E-01 (Median) | Methylation in Control | 9.37E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC3A1 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg10801607) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 4.97E-02; Z-score: -4.71E-01 | ||
Methylation in Case |
2.05E-01 (Median) | Methylation in Control | 2.34E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC3A1 in lung adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg03902905) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 1.35E-02; Z-score: -1.29E+00 | ||
Methylation in Case |
7.41E-01 (Median) | Methylation in Control | 7.68E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC3A1 in lung adenocarcinoma | [ 6 ] | |||
Location |
1stExon (cg02192965) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 4.83E-02; Z-score: -1.24E+00 | ||
Methylation in Case |
8.08E-01 (Median) | Methylation in Control | 8.53E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC3A1 in lung adenocarcinoma | [ 6 ] | |||
Location |
Body (cg10801607) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.38E+00 | Statistic Test | p-value: 1.81E-03; Z-score: 2.92E+00 | ||
Methylation in Case |
2.42E-01 (Median) | Methylation in Control | 1.75E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC3A1 in lung adenocarcinoma | [ 6 ] | |||
Location |
Body (cg24724513) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 3.88E-03; Z-score: -2.31E+00 | ||
Methylation in Case |
6.46E-01 (Median) | Methylation in Control | 6.93E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC3A1 in lung adenocarcinoma | [ 6 ] | |||
Location |
Body (cg21843262) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 1.16E-02; Z-score: -8.75E+00 | ||
Methylation in Case |
9.23E-01 (Median) | Methylation in Control | 9.78E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC3A1 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg00648005) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 1.84E-04; Z-score: -1.04E+00 | ||
Methylation in Case |
5.39E-01 (Median) | Methylation in Control | 6.06E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC3A1 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg04713352) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 5.93E-04; Z-score: -7.81E-01 | ||
Methylation in Case |
5.82E-01 (Median) | Methylation in Control | 6.29E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC3A1 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS200 (cg22113930) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 7.47E+00 | Statistic Test | p-value: 4.10E-07; Z-score: 2.05E+00 | ||
Methylation in Case |
4.07E-01 (Median) | Methylation in Control | 5.45E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC3A1 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS200 (cg06270147) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.23E+00 | Statistic Test | p-value: 3.64E-06; Z-score: 1.06E+00 | ||
Methylation in Case |
9.62E-02 (Median) | Methylation in Control | 7.81E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC3A1 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg04264781) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 5.32E-03; Z-score: 7.80E-01 | ||
Methylation in Case |
9.10E-01 (Median) | Methylation in Control | 8.86E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC3A1 in systemic lupus erythematosus | [ 8 ] | |||
Location |
TSS1500 (cg03902905) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.11E-03; Z-score: -2.60E-01 | ||
Methylation in Case |
7.20E-01 (Median) | Methylation in Control | 7.29E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC3A1 in atypical teratoid rhabdoid tumor | [ 9 ] | |||
Location |
1stExon (cg02192965) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.64E+00 | Statistic Test | p-value: 1.58E-27; Z-score: -6.58E+00 | ||
Methylation in Case |
5.64E-01 (Median) | Methylation in Control | 9.27E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC3A1 in atypical teratoid rhabdoid tumor | [ 9 ] | |||
Location |
1stExon (cg03217954) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.47E+00 | Statistic Test | p-value: 1.05E-25; Z-score: -4.50E+00 | ||
Methylation in Case |
5.86E-01 (Median) | Methylation in Control | 8.61E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC3A1 in atypical teratoid rhabdoid tumor | [ 9 ] | |||
Location |
Body (cg09860050) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 1.22E-02; Z-score: -3.88E-01 | ||
Methylation in Case |
8.51E-01 (Median) | Methylation in Control | 8.81E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC3A1 in atypical teratoid rhabdoid tumor | [ 9 ] | |||
Location |
Body (cg09959718) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 1.27E-02; Z-score: 4.54E-01 | ||
Methylation in Case |
8.89E-01 (Median) | Methylation in Control | 8.36E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC3A1 in atypical teratoid rhabdoid tumor | [ 9 ] | |||
Location |
Body (cg10801607) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 1.82E-02; Z-score: 7.53E-02 | ||
Methylation in Case |
1.91E-01 (Median) | Methylation in Control | 1.86E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC3A1 in HIV infection | [ 10 ] | |||
Location |
1stExon (cg02192965) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 3.36E-06; Z-score: -2.12E+00 | ||
Methylation in Case |
8.44E-01 (Median) | Methylation in Control | 9.09E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC3A1 in HIV infection | [ 10 ] | |||
Location |
Body (cg10801607) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.41E+00 | Statistic Test | p-value: 4.96E-07; Z-score: 2.15E+00 | ||
Methylation in Case |
2.99E-01 (Median) | Methylation in Control | 2.12E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC3A1 in HIV infection | [ 10 ] | |||
Location |
Body (cg24724513) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 6.27E-03; Z-score: -5.80E-01 | ||
Methylation in Case |
7.15E-01 (Median) | Methylation in Control | 7.36E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC3A1 in HIV infection | [ 10 ] | |||
Location |
Body (cg21843262) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 9.31E-03; Z-score: -9.70E-01 | ||
Methylation in Case |
9.79E-01 (Median) | Methylation in Control | 9.86E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC3A1 in HIV infection | [ 10 ] | |||
Location |
Body (cg09860050) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 2.01E-02; Z-score: -3.99E-01 | ||
Methylation in Case |
7.84E-01 (Median) | Methylation in Control | 7.97E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC3A1 in papillary thyroid cancer | [ 11 ] | |||
Location |
1stExon (cg02192965) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.44E-02; Z-score: -3.67E-01 | ||
Methylation in Case |
9.19E-01 (Median) | Methylation in Control | 9.28E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Unclear Phenotype |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-382 directly targets SLC3A1 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-382 | miRNA Mature ID | miR-382-5p | ||
miRNA Sequence |
GAAGUUGUUCGUGGUGGAUUCG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 2 |
miR-548e directly targets SLC3A1 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-548e | miRNA Mature ID | miR-548e-5p | ||
miRNA Sequence |
CAAAAGCAAUCGCGGUUUUUGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.